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Objectives: The aim of the study was to ﬁnd how to differentiate hyperdense middle cerebral
artery sign (HMCAS) in stroke patients from asymmetric hyperdensity not related to stroke,
by comparison of the CT density values typical for HMCAS to the values in normal or
atherosclerotic middle cerebral artery (MCA).
Methods: The group analyzed consisted of 100 patients with ischemic stroke, presenting
HMCAS on the admission CT. Density measurements in HU were performed in the hyper-
dense segment of the involved MCA, contralateral MCA, brain cortex adjacent to the
hyperdense MCA. The control group consisted of 100 patients with no symptoms of cerebral
stroke. Density measurements in HU were performed: in the M1 segment of right and left
MCA, brain cortex adjacent to the more dense from right or left MCA.
Results: In the stroke group the median values obtained were: in the hyperdense MCA 59 HU,
contralateral MCA 41 HU, brain cortex 36 HU. In the control group the median values
obtained were: in the more dense MCA 43 HU, contralateral MCA 40 HU, brain cortex
34 HU. The range of HMCAS/contralateral MCA density ratios in stroke only slightly overlapped
the range of more dense MCA/contralateral MCA density ratios in non-stroke patients.
Conclusion: The ratio of hyperdense MCA CT density/contralateral density is a good tool to
differentiate HMCAS from asymmetric hyperdensity not related to stroke. The threshold
≥1.16 provided 100% sensitivity and 97% speciﬁcity, whereas ≥1.22 provided 94% sensitivity
and 100% speciﬁcity.
© 2017 Published by Elsevier Sp. z o.o. on behalf of Polish Neurological Society.
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Non-contrast computed tomography (CT) brain examination is
still the most commonly used imaging modality in patients
with clinical symptoms of acute ischemic brain stroke [1–3].
The procedure is chosen as it is widely available, fast and
inexpensive. It is performed to rule out intracranial patholo-
gies mimicking stroke such as tumor, to exclude intracranial* Corresponding author.
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0028-3843/© 2017 Published by Elsevier Sp. z o.o. on behalf of Polish Nhemorrhage not allowing thrombolysis and also to assess
early symptoms of stroke.
In the hyperacute phase during the ﬁrst 3 h after onset,
typical brain tissue abnormalities possible to observe in CT
are: loss of gray-white matter differentiation, especially loss
of distinction among the nuclei of the basal ganglia (lenticular
obscuration), blending of the densities of the cortex and
underlying white matter in the insula (insular ribbon sign) and
over the convexities (cortical ribbon sign), as well as corticaleurological Society.
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ment.
In some patients, it is also possible to see in CT a
hyperdense segment of the artery, representing direct imaging
of an intravascular thrombus. Sometimes it may be the earliest
and only visible CT sign of ischemic stroke. This can be
localized in any vessel, but it is most often observed in the
middle cerebral artery (MCA) as hyperdense middle cerebral
artery sign (HMCAS) (Fig. 1).
Such increased attenuation may be found in a long segment
of MCA, especially the proximal portion or, usually distally,
may be limited to a very short segment, as an MCA dot sign.
In histopathological studies the composition of the
thrombus is deﬁned as typical for early phase (RBC – Red
Blood Cell Count dominant and RBC proportion equal to ﬁbrin)
and late phase (ﬁbrin dominant and organized ﬁbrin).
Hyperdense artery sign on CT is usually seen in early phase
thrombus composition [4,5].
HMCAS recognition is crucial for radiologists, because it
may help to save the patient in the proper time window for
thrombolysis (4.5 h from stroke onset to rtPA treatment [1]).
HMCAS may be a valuable predictor of the ﬁnal severity of
stroke. In patients with cerebral ischemic stroke involving MCA
region and no early signs of brain tissue ischemia on admission
CT, HMCAS is associated with signiﬁcantly lower Alberta Stroke
Program Early CT Score (ASPECTS) in the follow up CT. Long
hyperdense MCA segment is generally associated with a large
area of brain tissue damage; however, short hyperdense MCA
segment does not exclude large area of brain tissue damage [6].
In patients with HMCAS shown by baseline CT, treated with
intravenous thrombolysis, the size of hyperdense MCA
segment correlates with the effects of treatment and the ﬁnal
outcome. Shobha [7] found that short-length HMCAS (<10 mm)
disappeared in 85.7% of cases, medium-length HMCAS
(10–20 mm) – in 37.5% and long-length HMCAS (>20 mm)
did not disappear in any of the cases.Fig. 1 – Hyperdense middle cerebral arteThe persistence of HMCAS on the follow-up CT after int-
ravenous thrombolysis is an early predictor of poor functional
outcome [8,9].
Furthermore, the location of the thrombus in the proximal
or distal part of the vessel is important for the prognosis of the
patient. Man [10] found that proximal HMCAS predicts an
unfavorable outcome of intraarterial thrombectomy for acute
stroke. Similarly, Li [11] showed that poor neurological
recovery post intravenous thrombolysis was conﬁned to
proximal HMCAS cases, contrary to distal HMCAS cases.
Zou [12] concluded that HMCAS is also associated with
increased risk of hemorrhagic transformation after intrave-
nous thrombolysis for patients with acute ischemic stroke.
HMCAS is seen in about one third to one half of cases of
angiographically (DSA – digital subtraction angiography)
proven thromboses [13,14], so the sensitivity is rather low.
The speciﬁcity of the sign is much higher, however, in some
cases, false positive results of HMCAS are reported, because of
advanced atherosclerotic disease, especially with asymmetric
calciﬁcations.
Commonly, it is easy to conﬁrm a calciﬁed plaque as a
reason for a hyperdense vessel segment, because of high CT
density values typical for calciﬁcations.
However, in some, usually older patients, a generally
increased density of the arterial wall is observed, but not
reaching the threshold of calciﬁcations. Such a hyperdense
vessel on the background of adjacent brain tissue may be
misinterpreted as HMCAS, particularly in asymmetric head
position during scanning (Fig. 2).
Apart from atherosclerosis, there are only very rare reports
of false positive HMCAS seen in herpes simplex virus (HSV)
encephalitis [15].
The aim of the study was to ﬁnd how to differentiate HMCAS
in stroke patients from asymmetric hyperdensity unrelated to
stroke, by comparison of the CT density values typical for
HMCAS to the values in normal or atherosclerotic MCA.ry sign (HMCAS) in a stroke patient.
Fig. 2 – Generally increased density of the arterial wall because of atherosclerosis in a non-stroke patient.
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The group retrospectively analyzed consisted of 100 patients –
48 females and 52 males, aged 39–97 years (mean 74 years, SD
11.2 years), with cerebral ischemic stroke involving MCA
region, diagnosed and treated in the University Hospital in
Cracow in the years 2011–2016, presenting hyperdense middle
cerebral artery sign (HMCAS) on the admission CT examina-
tion and with infarcts conﬁrmed on the follow-up CT.
In all the patients analyzed we observed a change in the
density or size of the hyperdense segment on the follow-up CT.
Thus, our study design assumed that HMCAS observed was
due to the acute occlusion of this hyperdense segment of the
artery.
In 51 (51%) patients stroke involved the left MCA region,
whereas in 49 (49%) patients – the right MCA region.
In all the patients from the analyzed group CT density
measurements in HU were performed:
- in the hyperdense segment of the involved MCA,
- in the symmetrical segment of the contralateral MCA,
- in the brain cortex adjacent to the hyperdense MCA segment.
Subsequently the following ratios were calculated:
- hyperdense segment density/contralateral segment density,
- hyperdense segment density/brain cortex density,
- contralateral segment density/brain cortex density.
The control group consisted of 100 patients – 55 females
and 45 males, aged 50–94 years (mean 74 years, SD 12.3 years),
diagnosed in the University Hospital in Cracow in the year2015, with no clinical or radiological symptoms of cerebral
stroke.
In all the patients from the control group CT density
measurements in HU were performed:
- in the M1 segment of the right MCA,
- in the M1 segment of the left MCA,
- in the brain cortex adjacent to the more dense from right or
left M1 MCA segments measured as above.
Then the following ratios were calculated:
- the more dense from right or left M1 segment density/
contralateral M1 segment density,
- the more dense from right or left M1 segment density/brain
cortex density,
- contralateral M1 segment density/brain cortex density.
All the CT brain examinations were performed using
no intravenous contrast media, 2.5 mm or 3 mm slices,
120–130 kV, 102–342 mAs.
All the density measurements were performed twice and
averaged to reduce the measurement errors. In every case ROI
(region of interest) was adjusted to cover only the measured
artery or brain cortex.
The statistical tests used during comparisons were:
Wilcoxon's test (a non-parametrical alternative to Student's
t-test for dependent samples), Welch's t-test (an alternative to
Student's t-test for independent samples, if variances equality
is not conﬁrmed using Levene's test), Mann–Whitney's test (an
alternative to Student's t-test for independent samples if the
distribution of a feature is not normal).
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between the distribution of a feature and theoretical normal
distribution.
The statistical calculation was made by R software version
3.3.1 (www.r-project.org).
3. Results
In the group of patients with stroke and HMCAS the CT density
measurements were as follows:
- in the hyperdense segment of the involved MCA median
59 HU (41–78 HU, SD 6.9 HU),
- in the symmetrical segment of the contralateral MCA
median 41 HU (30–59 HU, SD 5.5 HU),
- in the brain cortex adjacent to the hyperdense MCA segment
median 36 HU (27–48 HU, SD 4.2 HU).
The following ratios were obtained:
- hyperdense segment density/contralateral segment density
median 1.43 (1.16–2.03, SD 0.2),
- hyperdense segment density/brain cortex density median
1.65 (1.06–2.70, SD 0.3),
- contralateral segment density/brain cortex density median
1.15 (0.73–1.93, SD 0.2).
In the control group of patients with no stroke the CT
density measurements were as follows:
- in the M1 segment of the right MCA median 42 HU (30–54 HU,
SD 4.5 HU),
- in the M1 segment of the left MCA median 41 HU (31–49 HU,
SD 3.9 HU),
- in the more dense from right or left M1 MCA segments
measured as above median 43 HU (31–54 HU, SD 4.3 HU),Fig. 3 – Box and whiskers diagram: HMCAS density - in the contralateral M1 MCA segment median 40 HU (30–49
HU, SD 3.9 HU),
- in the brain cortex adjacent to the more dense from right or
left M1 MCA segments median 34 HU (24–44 HU, SD 3.4 HU).
The following ratios were obtained:
- the more dense from right or left M1 segment density/
contralateral M1 segment density median 1.05 (1.00–1.21, SD
0.0),
- the more dense from right or left M1 segment density/brain
cortex density median 1.24 (0.88–1.74, SD 0.2),
- contralateral M1 segment density/brain cortex density
median 1.17 (0.85–1.55, SD 0.1).
The measurements of the absolute values of CT densities
revealed that the HMCAS density in stroke was of course
signiﬁcantly higher than both contralateral MCA density in
stroke (Fig. 3) ( p < 0.001 in Wilcoxon's test) and the more dense
MCA density in non-stroke patients (Fig. 4) ( p < 0.001 in
Welch's test).
However the range of HMCAS density values largely
overlapped the ranges of the other foregoing values.
The vessel CT density/adjacent brain cortex density ratio
deﬁnes the relative 'brightness' of vessel on the background of
darker brain tissue.
The HMCAS/brain cortex density ratio in stroke was also
signiﬁcantly higher than both the contralateral MCA/brain
cortex density ratio in stroke (Fig. 5) ( p < 0.001 in Wilcoxon's
test) and more dense MCA/brain cortex density in non-stroke
patients (Fig. 6) ( p < 0.001 in Mann–Whitney's test).
However, again the range of HMCAS/brain cortex density
ratios largely overlapped the ranges of the other foregoing
ratios.
Finally, the hyperdense vessel density/contralateral vessel
density ratio deﬁnes the relative 'brightness' of vessel
compared to the contralateral vessel.vs. contralateral MCA density in stroke patients.
Fig. 4 – Box and whiskers diagram: HMCAS density in stroke vs. more dense MCA density in non-stroke patients.
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signiﬁcantly higher than more dense MCA/contralateral MCA
density ratio in non-stroke patients (Fig. 7) ( p < 0.001 in Mann–
Whitney's test).
The range of HMCAS/contralateral MCA density ratios in
stroke only slightly overlapped the range of more dense MCA/
contralateral MCA density ratios in non-stroke patients.
Using the threshold ≥ 1.16 for the hyperdense vessel
segment/contralateral vessel segment density ratio it was
possible to differentiate HMCAS in stroke patients from
asymmetric hyperdensity not related to stroke in non-stroke
patients with 100% sensitivity and 97% speciﬁcity.Fig. 5 – Box and whiskers diagram: HMCAS to brain cortex dens
patients.Using the threshold ≥ 1.22 for the hyperdense vessel
segment/contralateral vessel segment density ratio it
was possible to differentiate HMCAS in stroke patients
from asymmetric hyperdensity not related to stroke
in non-stroke patients with 94% sensitivity and 100%
speciﬁcity.
4. Discussion
Accurate diagnosis of HMCAS in acute stroke patients is very
important, because the sign is typically associated with aity vs. contralateral MCA to brain cortex density in stroke
Fig. 6 – Box and whiskers diagram: HMCAS to brain cortex density in stroke vs. more dense MCA to brain cortex density in
non-stroke patients.
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neurological deﬁcits and worse effects of thrombolytic
treatment [13,16–19].
In most of the papers concerning HMCAS, it is deﬁned only
qualitatively, for example as ‘‘MCA denser than its contralat-
eral counterpart’’ [20,21], ‘‘more dense than adjacent or
equivalent contralateral arteries but noncalciﬁed’’ [22] or
‘‘density of the MCA higher than that of the surrounding
brain, with disappearance on bone window and unilaterality’’
[23,8] or simply as ‘‘classiﬁcation done by a local radiologist
according to general practice’’ [19].Fig. 7 – Box and whiskers diagram: HMCAS to contralateral MCA
contralateral MCA density in non-stroke patients.Liebeskind [4] reported the mean attenuation of HMCAS as
61 HU (8) for the group of only 10 HMCAS cases analyzed in
his research. His value is close to our result 59 HU.
Simons [5] before histopathological study of thrombus
extracted by endovascular retrieval, measured the mean
attenuation of hyperdense artery as 43.1 HU (8.7) for the
group of 29 cases, however it included not only MCA, but also
ICA (internal cervical artery) and basilar artery.
Koo [15] found the mean attenuation of HMCAS as 54 HU
(46.7–61.2 HU), versus 41.9 HU (37.3–61.1 HU) in unaffected
vessels and 41.3 HU (39.7–43.0) in non-stroke controls. Because density in stroke patients vs. more dense MCA to
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he suggested to use not only the criterion of absolute density
>43 HU, but additionally the ratio of hyperdense MCA density/
contralateral vessel density >1.2 to get a 100% speciﬁcity.
However his work included only 18 cases of stroke patients.
The ratio threshold 1.2 is very close to our result, and the
mean density values of 54 HU for HMCAS and 41.9 HU for
unaffected vessels are close to our values – respectively 59 HU
and 43 HU.
Haridy [24] in a subgroup of 106 patients with stroke and
HMCAS present, found the mean attenuation of HMCAS as
59 HU and the median ratio of hyperdense MCA density/
contralateral MCA density as 1.44 (1.09–2.00), whereas in a
subgroup of 48 patients with stroke but HMCAS absent he
found the mean attenuation of affected MCA as 42.9 HU and
the median ratio of affected MCA density/contralateral MCA
density as 1.02 (0.84–1.47).
In his subgroup with stroke and HMCAS present, the mean
attenuation of HMCAS as 59 HU is the same as in our study and
the median ratio of hyperdense MCA density/contralateral MCA
density as 1.44 is practically the same as in our study – 1.43.
However in his subgroup with stroke and HMCAS absent,
the upper limit of range (0.84–1.47) for the ratio of affected
MCA density/contralateral MCA density is rather difﬁcult to
explain – why the artery almost 1.5 times denser then the
contralateral one was not classiﬁed as HMCAS according to
Haridy's own qualitative deﬁnition: ‘‘HMCA deﬁned as an MCA
denser than its contralateral counterpart’’?
Detection and assessment of HMCAS on routine non-
contrast CT examinations may be limited by large slice
thickness of up to 5 mm, compared to the MCA diameter of
only 2–3 mm. It results in partial volume effects blurring the
intraluminal hyperdensity and lowering HMCAS detection
sensitivity. Therefore, some authors suggest using thin slices
of about 1 mm for the assessment of non-contrast CT
examinations performed using multidetector CT scanners in
stroke patients, which may considerably increase the sensi-
tivity [22,25,26].
In our study we used slice thickness of 2.5–3 mm, com-
parable to the MCA diameter.
In cases of borderline values obtained of the hyperdense
MCA segment CT density/contralateral segment density ratio,
to increase the accuracy, it is suggested to perform additional
reconstruction of axial slices from raw CT data, using as thin
slices as possible. In many CT scanners it may be performed,
because a standard brain protocol typically uses thicker slices
to reduce noise for brain tissue.
In some portion of patients with acute partial anterior
circulation stroke (PACS according to Oxfordshire Community
Stroke Project (OCSP) classiﬁcation), hyperdensity of MCA is
the effect of atherosclerosis, but the more distant acutely
occluded portion of the artery is either non-hyperdense or
simply undetectable in CT. In our study, in all the patients with
cerebral ischemic stroke and HMCAS on the admission CT, we
observed a change in the density or size of the hyperdense
segment on the follow-up CT. Thus, our study design assumed
that HMCAS observed was due to the acute occlusion of this
hyperdense segment of the artery. Of course, in clinical
practice, using only admission CT, it is not possible to assess
the dynamics of change. Thus everybody should be aware ofthe case of false positive HMCAS in a patient with more distant
non-hyperdense occluded portion of the artery. However, in
such a case, our study results may help to conﬁrm hyperden-
sity as the effect of atherosclerosis.
CTA (computed tomography angiography) performed
just after non-contrast CT during the same session, provides
direct imaging of real location and size of the thrombus. Thus,
using CTA as the veriﬁcation technique for patients with
cerebral ischemic stroke and HMCAS on non-contrast CT,
would be an excellent method to measure the sensitivity
and speciﬁcity of HMCAS. Unfortunately in our group of 100
patients presenting HMCAS on the admission CT, in 65 cases
no CTA was performed during the same session, so we used
follow-up CT with infarcts conﬁrmed, as the veriﬁcation
technique. However, the aim of our study was not to assess the
real sensitivity and speciﬁcity of HMCAS, but only to ﬁnd how
to differentiate HMCAS in stroke patients from asymmetric
hyperdensity not related to stroke.
5. Conclusions
The ratio of hyperdense MCA segment CT density/contralat-
eral segment density may be a good tool to differentiate
HMCAS in stroke patients from asymmetric hyperdensity
unrelated to stroke. In our study the threshold of this
ratio ≥ 1.16 provided 100% sensitivity and 97% speciﬁcity,
whereas ≥ 1.22 94% sensitivity and 100% speciﬁcity.
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